CONTROLLED PHASE-III CLINICAL-STUDY OF 4-EPI-DOXORUBICIN + 5-FLUOROURACIL VERSUS 5-FLUOROURACIL ALONE IN METASTATIC GASTRIC AND RECTOSIGMOID CANCER

被引：25

作者：

KOLARIC, K ^{[1
]}

POTREBICA, V ^{[1
]}

STANOVNIK, M ^{[1
]}

机构：

[1] INST ONCOL,LJUBLJANA,YUGOSLAVIA

来源：

ONCOLOGY | 1986年 / 43卷 / 02期

关键词：

D O I：

10.1159/000226337

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：73 / 77

页数：5

共 22 条

[1] SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE [J].

ARCAMONE, F ;

PENCO, S ;

VIGEVANI, A ;

REDAELLI, S ;

FRANCHI, G ;

DIMARCO, A ;

CASAZZA, AM ;

DASDIA, T ;

FORMELLI, F ;

NECCO, A ;

SORANZO, C .

JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (07) :703-707

[2]

BATTELLI T, 1982, PHASE 2 CLIN STUDY 4

[3] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN [J].

BONFANTE, V ;

VILLANI, F ;

BONADONNA, G .

TUMORI JOURNAL, 1982, 68 (02) :105-111

[4]

BONFANTE V, 1979, CANCER TREAT REP, V63, P915

[5]

BONFANTE V, 1980, RECENT RESULTS CANCE, P202

[6]

BROGGINI M, 1980, CANCER TREAT REP, V64, P897

[7]

CASAZZA AM, 1979, CANCER TREAT REP, V63, P835

[8]

CASAZZA AM, 1978, CURRENT CHEMOTHERAPY, P1257

[9]

CORTESFUNES H, 1982, PHASE 2 STUDY 4 EPI

[10]

DELLACUNA GR, TUMORI

← 1 2 3 →